Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Celltrion (068270) – CHMP Positive Opinion Granted for CT-P43 (Stelara Biosimilar) by EMA / 2024-07-01 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Investor Relations (IR) Announcement / 2025-05-28 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – Report on Reasons for Holding General Meeting of Shareholders on Concentrated Date / 2025-03-06 Semiconductors
  • [Disclosure] ALTEOGEN (196170) – Change in Revenue or Income Structure Exceeding 30% (15% for Large Corporations) / 2024-03-11 Disclosures
  • [Disclosure] KEPCO (015760 / KEP) – (Correction) Filing of Legal Proceedings / 2026-05-22 Disclosures
  • [Disclosure] SK Hynix (000660 / SKHY) – Clarification of Rumors or News Reports / 2026-06-16 Semiconductors
  • [Research] Samsung Electro-Mechanics (009150) – IBK Securities | Expanding Non-IT MLCC · Substrate Mix Improvement · Earnings Trajectory / 2025-08-01 RESEARCH
  • [Disclosure] Hanwha Ocean (042660) – Decision on Paid-in Capital Increase / 2024-06-14 Disclosures

[Disclosure] ALTEOGEN (196170) – Decision on Paid-in Capital Increase (Third-Party Allotment – Redeemable Convertible Preferred Shares) / 2025-02-04

Posted on February 4, 2025August 5, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Alteogen decided on a third-party allotment paid-in capital increase issuing Redeemable Convertible Preferred Shares (RCPS) worth KRW 155.00B to fund plant construction, headquarters relocation, and operating expenses.

📊 [Key Disclosure Details & Financial Highlights]

  • Type & Number of Shares: 434,848 Registered Redeemable Convertible Preferred Shares (RCPS)
  • Total Capital Raised: KRW 154,994,177,184 (Approx. KRW 155.00B)
    • Facility Funds: KRW 54,994,177,184 (Plant construction and headquarters relocation)
    • Operating Funds: KRW 100,000,000,000
  • Method of Issuance: Third-party allotment
  • Issue Price per Share: KRW 356,433 (2.3145% premium over the reference price of KRW 348,370)
  • Key Schedules:
    • Payment Date: 2025-02-19
    • Scheduled Delivery Date of New Shares: 2025-03-05
    • Board Resolution Date: 2025-02-04
  • Key RCPS Terms:
    • Voting Rights: Non-voting (Voting rights granted if preferred dividend is unapproved)
    • Duration: 5 years from issuance (Expires 2030-02-20, automatically converts to common stock upon expiration)
    • Dividend Rate: 1.0% per annum of par value (Cumulative, Participating)
    • Redemption Claim Period: 2028-02-20 ~ 2030-01-20 (After 3 years from issuance, 1.0% annual compound interest)
    • Conversion Claim Period: 2026-02-20 ~ 2030-01-20 (After 1 year from issuance)
    • Conversion Price Refixing: Floor price set at KRW 302,969 (85% of initial conversion price)
    • Lock-up: 100% of issued shares subject to 1-year mandatory lock-up with Korea Securities Depository
  • Key Allottees: KB Naou Special Situation PEF, KB-Solidus Healthcare Investment Association, NH Investment & Securities, DB Financial Investment, Kiwoom Securities, among other institutional funds and brokerages

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Full Capital Payment and 1-Year Lock-up Setup

This filing outlines a KRW 155.00B private RCPS issuance designed to finance manufacturing facility expansion and general operations. Verifying whether the full payment is successfully deposited by the scheduled payment date (February 19, 2025) and confirming the execution of the 1-year mandatory lock-up with the depository is important to check the formal completion of this transaction. The settlement details and share count updates can be verified in the subsequent ‘Result of Securities Issuance’ disclosure and the ‘Total Number of Shares’ section of future periodic financial reports.

📢 Disclaimer & Source Information

Source: This content was structured and generated based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For inquiries regarding regulatory compliance or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] ISU PETASYS (007660) – Advance Notice of Designation as Unfaithful Disclosure Company / 2025-02-04
Next Post: [Disclosure] Hanwha Ocean (042660) – Investor Relations (IR) Announcement / 2025-02-04

Related Posts

  • [Disclosure] Hanwha Aerospace (012450) – Decision on Cash/In-Kind Dividend / 2024-02-23 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Other Major Management Matters (Voluntary Disclosure) / 2024-10-31 Semiconductors
  • [Disclosure] HPSP (403870) – Change of CEO / 2025-11-07 Semiconductors
  • [Disclosure] Hanmi Semiconductor (042700) – Investor Relations (IR) Presentation / 2024-08-28 Semiconductors
  • [Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2025-09-17 Disclosures
  • [Disclosure] PSK Holdings (031980) – Submission of Audit Report / 2024-03-21 Semiconductors
  • [Disclosure] Hanwha Ocean (042660) – Correction of Decision on Loan to Related Party / 2024-11-26 Disclosures
  • [Research] SK hynix (000660 / SKHY) – DS Investment & Securities | In-line 4Q24 Outlook · Custom HBM Entry · Target Price Maintained / 2025-01-10 RESEARCH
  • [Disclosure] Jusung Engineering (036930) – Investor Relations (IR) Presentation / 2025-08-25 Semiconductors
  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07 Disclosures
  • [Disclosure] Daeduck Electronics (353200) – Invitation to Investor Relations (IR) / 2026-07-16 Disclosures
  • [Disclosure] Daeduck Electronics (353200) – Resolution on Board Decision to Convene Annual General Meeting of Shareholders / 2025-02-20 Semiconductors
  • [Research] Samsung Electronics (005930) – IBK Investment & Securities | DS Earnings · Datacenter LTA · HBM4 Ramp / 2026-07-31 RESEARCH
  • [Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P51 (Keytruda Biosimilar) in Europe (Part 1 & 2) / 2024-08-23 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme